Stay updated on T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A new page revision is recorded (v3.6.3) replacing the earlier revision (v3.6.2) in the study's history. This reflects an update to the page metadata rather than substantive study details.
    Difference
    0.1%
    Check dated 2026-07-03T23:51:51.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The revision history now shows a new entry for v3.6.2, replacing the prior v3.6.0 in the study record.
    Difference
    0.1%
    Check dated 2026-06-26T20:25:33.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Recruitment status was updated to 'No longer looking for participants', indicating enrollment has ended. The record history was updated to Revision: v3.6.0, replacing the previous revision (v3.5.5).
    Difference
    0.7%
    Check dated 2026-06-12T16:09:36.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The history now shows a new software revision entry (v3.5.5) and removes the prior revision (v3.5.4), indicating a new site release was logged.
    Difference
    0.1%
    Check dated 2026-06-05T11:54:16.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page history now shows a new revision tag, v3.5.4, added to the study record history. This updates the record with a newer revision, replacing the prior v3.5.3 entry.
    Difference
    0.1%
    Check dated 2026-05-15T03:06:27.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    A minor platform/version indicator on the page changes from Revision: v3.5.2 to Revision: v3.5.3, with no visible update to the underlying trial record history.
    Difference
    0.1%
    Check dated 2026-04-23T21:54:11.000Z thumbnail image

Stay in the know with updates to T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.